Capricor Therapeutics (CAPR) Institutional Ownership $11.15 +0.97 (+9.53%) Closing price 06/27/2025 04:00 PM EasternExtended Trading$11.16 +0.00 (+0.04%) As of 06/27/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Capricor Therapeutics (NASDAQ:CAPR)CurrentInstitutional OwnershipPercentage21.68%Number ofInstitutional Buyers(last 12 months)79TotalInstitutional Inflows(last 12 months)$115.33MNumber ofInstitutional Sellers(last 12 months)11TotalInstitutional Outflows(last 12 months)$2.25M Get CAPR Insider Trade Alerts Want to know when executives and insiders are buying or selling Capricor Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CAPR Institutional Buying and Selling by Quarter Capricor Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails6/27/2025 Goldman Sachs Group Inc.411,141$3.90M0.0%+39.5%0.900% 5/29/2025 Rhumbline Advisers49,814$473K0.0%+8.1%0.109% 5/16/2025 Woodline Partners LP729,318$6.92M0.0%+15.8%1.597% 5/16/2025 Octagon Capital Advisors LP450,000$4.27M0.5%N/A0.985% 5/16/2025 Goldman Sachs Group Inc.411,141$3.90M0.0%+39.5%0.900% 5/16/2025 AWM Investment Company Inc.87,765$833K0.1%N/A0.192% 5/14/2025 Rafferty Asset Management LLC82,988$788K0.0%-34.3%0.182% 5/14/2025 Connective Capital Management LLC23,128$219K0.2%N/A0.051% 5/14/2025 Worth Venture Partners LLC16,345$155K0.3%N/A0.036% 5/14/2025 Jump Financial LLC163,021$1.55M0.0%N/A0.357% Get the Latest News and Ratings for CAPR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Capricor Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/14/2025 Stoneridge Investment Partners LLC15,853$150K0.1%N/A0.035% 5/14/2025 Wellington Management Group LLP110,731$1.05M0.0%+170.3%0.242% 5/13/2025 Fox Run Management L.L.C.22,360$212K0.0%N/A0.049% 5/13/2025 Caitong International Asset Management Co. Ltd22,495$213K0.2%+18,188.6%0.049% 5/12/2025 Nuveen LLC89,141$846K0.0%N/A0.195% 5/12/2025 Swiss National Bank79,300$753K0.0%+17.7%0.174% 5/9/2025 Deutsche Bank AG28,699$272K0.0%+10.9%0.063% 5/9/2025 Charles Schwab Investment Management Inc.113,650$1.08M0.0%+2.1%0.249% 5/9/2025 Citizens Financial Group Inc. RI10,023$95K0.0%N/A0.022% 5/9/2025 Vanguard Group Inc.2,263,991$21.49M0.0%-0.6%4.957% 5/8/2025 XTX Topco Ltd54,870$521K0.0%N/A0.120% 5/7/2025 Zurcher Kantonalbank Zurich Cantonalbank 13,246$126K0.0%+31.4%0.029% 5/1/2025 Arizona State Retirement System11,707$111K0.0%N/A0.026% 4/30/2025 Alps Advisors Inc.33,230$315K0.0%-9.6%0.073% 4/29/2025 Bank of New York Mellon Corp87,720$832K0.0%+4.4%0.192% 4/28/2025 Acuitas Investments LLC21,530$204K0.2%N/A0.047% 4/23/2025 HBK Sorce Advisory LLC49,844$473K0.0%N/A0.109% 4/23/2025 Oppenheimer & Co. Inc.129,195$1.23M0.0%+24.0%0.283% 4/16/2025 Krilogy Financial LLC22,800$216K0.0%+9.6%0.050% 4/8/2025 Rhumbline Advisers49,814$473K0.0%+8.1%0.109% 3/24/2025 Wellington Management Group LLP40,959$565K0.0%N/A0.090% 3/18/2025 California State Teachers Retirement System32,237$445K0.0%+1,653.0%0.071% 2/17/2025 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC33,498$462K0.0%N/A0.074% 2/17/2025 Voloridge Investment Management LLC121,623$1.68M0.0%N/A0.267% 2/17/2025 Woodline Partners LP629,934$8.69M0.1%N/A1.385% 2/17/2025 Two Sigma Investments LP119,047$1.64M0.0%+223.6%0.262% 2/17/2025 Rafferty Asset Management LLC126,311$1.74M0.0%N/A0.278% 2/17/2025 ProShare Advisors LLC10,317$142K0.0%N/A0.023% 2/17/2025Nuveen Asset Management LLC169,111$2.33M0.0%+392.7%0.372% 2/17/2025 Maven Securities LTD150,000$2.07M0.1%N/A0.330% The $7 company helping Nvidia build the world’s first trillion-dollar robot … (Ad)Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profitable trends in tech … well ahead of Wall Street. Like when he called Nvidia at a mere 80 cents a share. Or Bitcoin when it was trading for just $300. Throughout his illustrious career … Michael has given his followers almost 150 different chances to register triple-digit gains.Now he's identified his next potential winner. Click here to find out more.2/17/2025 Millennium Management LLC115,642$1.60M0.0%+11.9%0.254% 2/17/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.25,750$355K0.0%+82.1%0.057% 2/17/2025 Janus Henderson Group PLC16,400$226K0.0%N/A0.036% 2/17/2025 Farallon Capital Management LLC2,250,400$31.06M0.2%N/A4.949% 2/17/2025 Deutsche Bank AG25,877$357K0.0%N/A0.057% 2/17/2025 D. E. Shaw & Co. Inc.53,734$742K0.0%N/A0.118% 2/17/2025 Bank of America Corp DE170,543$2.35M0.0%+938.9%0.375% 2/17/2025 BNP Paribas Financial Markets3,622$50K0.0%-79.5%0.008% 2/14/2025 Freestone Grove Partners LP22,920$316K0.0%N/A0.050% 2/14/2025 Northern Trust Corp384,157$5.30M0.0%+43.3%0.845% 2/14/2025 The Manufacturers Life Insurance Company12,919$178K0.0%+22.4%0.028% 2/14/2025 Virtus ETF Advisers LLC4,957$68K0.0%N/A0.011% 2/14/2025 Voya Investment Management LLC10,850$150K0.0%N/A0.024% 2/14/2025 Price T Rowe Associates Inc. MD14,242$197K0.0%N/A0.031% 2/14/2025 Tower Research Capital LLC TRC6,197$86K0.0%-74.0%0.014% 2/14/2025 MetLife Investment Management LLC22,686$313K0.0%N/A0.050% 2/14/2025 Altium Capital Management LLC714,000$9.85M2.8%+150.5%1.570% 2/13/2025 Marshall Wace LLP59,303$818K0.0%N/A0.130% 2/13/2025 EAM Investors LLC38,276$528K0.1%-45.3%0.084% 2/13/2025 Barclays PLC89,650$1.24M0.0%+147.0%0.197% 2/13/2025 Summit Investment Advisors Inc.3,832$53K0.0%+54.1%0.008% 2/13/2025 Kennedy Capital Management LLC144,250$1.99M0.0%N/A0.317% 2/13/2025 Legal & General Group Plc30,783$425K0.0%+1,029.7%0.068% 2/13/2025 Invesco Ltd.14,678$203K0.0%+20.5%0.032% 2/13/2025 Russell Investments Group Ltd.4,652$64K0.0%+172.8%0.010% 2/13/2025 Wells Fargo & Company MN39,491$545K0.0%-10.5%0.087% 2/12/2025 Bryce Point Capital LLC22,709$313K0.1%N/A0.050% 2/12/2025 Geode Capital Management LLC879,468$12.14M0.0%+37.8%1.934% 2/12/2025 Alliancebernstein L.P.13,280$183K0.0%N/A0.029% 2/12/2025 Wellington Management Group LLP40,959$565K0.0%N/A0.090% 2/12/2025 JPMorgan Chase & Co.16,680$230K0.0%-70.3%0.037% 2/11/2025 Corebridge Financial Inc.18,212$251K0.0%+32.2%0.040% 2/11/2025 Vanguard Group Inc.2,276,784$31.42M0.0%+44.4%5.007% 2/11/2025 KLP Kapitalforvaltning AS6,600$91K0.0%N/A0.015% 2/11/2025 Teacher Retirement System of Texas10,243$141K0.0%N/A0.023% 2/11/2025 Intech Investment Management LLC16,546$228K0.0%N/A0.036% 2/10/2025 Swiss National Bank67,400$930K0.0%N/A0.148% 2/7/2025 AlphaQuest LLC5,676$78K0.0%N/A0.012% 2/6/2025 Charles Schwab Investment Management Inc.111,336$1.54M0.0%+51.5%0.245% 2/5/2025 Oppenheimer & Co. Inc.104,231$1.44M0.0%+52.4%0.229% 2/4/2025 Bank of New York Mellon Corp84,027$1.16M0.0%+32.6%0.185% 2/4/2025 Black Diamond Financial LLC277,737$3.83M0.6%N/A0.611% 1/31/2025 New York State Common Retirement Fund5,800$80K0.0%+625.0%0.013% 1/30/2025 Rhumbline Advisers46,083$636K0.0%+44.4%0.101% 1/17/2025 SG Americas Securities LLC15,317$211K0.0%+74.8%0.034% 1/17/2025 Magnus Financial Group LLC20,000$276K0.0%N/A0.044% 1/15/2025 Krilogy Financial LLC20,800$287K0.0%N/A0.046% 12/26/2024 JPMorgan Chase & Co.56,199$855K0.0%+419.5%0.124% 11/20/2024 Virtu Financial LLC30,112$458K0.0%N/A0.066% 11/19/2024 Barclays PLC36,296$552K0.0%+106.6%0.080% Israel-Iran WAR Could Destroy Trump's Presidency (Ad)The missiles are already flying. Israel and Iran are now in direct military conflict — and this couldn't have happened at a worse time. Trump is already dealing with Biden's $34 trillion debt bomb AND now a Middle East war. This is exactly what the "resistance" has been waiting for.Get Your Free Presidential Transition Guide Now »11/16/2024 Geode Capital Management LLC638,189$9.71M0.0%-0.5%1.405% 11/15/2024 Barclays PLC36,296$552K0.0%+106.6%0.080% 11/15/2024 Sphera Funds Management LTD.61,698$938K0.1%N/A0.136% 11/15/2024 State Street Corp512,313$7.79M0.0%+27.8%1.128% 11/15/2024 Sassicaia Capital Advisers LLC12,600$192K0.6%N/A0.028% 11/15/2024 Point72 Asset Management L.P.250,204$3.81M0.0%N/A0.551% 11/14/2024 PFM Health Sciences LP152,779$2.32M0.1%N/A0.336% 11/14/2024 Fred Alger Management LLC26,241$399K0.0%N/A0.058% 11/13/2024 BNP Paribas Financial Markets17,699$269K0.0%+868.7%0.039% 11/13/2024 FMR LLC24,344$370K0.0%N/A0.054% (Data available from 1/1/2016 forward) CAPR Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CAPR shares? During the previous two years, 86 institutional investors and hedge funds held shares of Capricor Therapeutics. The most heavily invested institutionals were Farallon Capital Management LLC ($31.06M), Vanguard Group Inc. ($21.49M), Geode Capital Management LLC ($12.14M), Altium Capital Management LLC ($9.85M), State Street Corp ($7.79M), Woodline Partners LP ($6.92M), and Northern Trust Corp ($5.30M).Learn more on Capricor Therapeutics' institutional investors. What percentage of Capricor Therapeutics' stock is owned by institutional investors? 21.68% of Capricor Therapeutics' stock is owned by institutional investors. Learn more on CAPR's institutional investor holdings. Which institutional investors have been buying Capricor Therapeutics' stock? Of the 81 institutional investors that purchased Capricor Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Farallon Capital Management LLC ($2.25M), Vanguard Group Inc. ($900.74K), Woodline Partners LP ($729.32K), Octagon Capital Advisors LP ($450K), Altium Capital Management LLC ($429K), Black Diamond Financial LLC ($277.74K), and Point72 Asset Management L.P. ($250.20K). How much institutional buying is happening at Capricor Therapeutics? Institutional investors have bought a total of 8,887,656 shares in the last 24 months. This purchase volume represents approximately $115.33M in transactions. Which of Capricor Therapeutics' major shareholders have been selling company stock? Of the 11 institutional investors that sold Capricor Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Rafferty Asset Management LLC ($43.32K), JPMorgan Chase & Co. ($39.52K), EAM Investors LLC ($31.65K), Tower Research Capital LLC TRC ($17.63K), BNP Paribas Financial Markets ($14.08K), Vanguard Group Inc. ($12.79K), and Activest Wealth Management ($5K). How much institutional selling is happening at Capricor Therapeutics? Institutional investors have sold a total of 180,403 shares in the last 24 months. This volume of shares sold represents approximately $2.25M in transactions. Related Companies LGND Institutional Ownership NAMS Institutional Ownership BHC Institutional Ownership ARWR Institutional Ownership KNSA Institutional Ownership AGIO Institutional Ownership SRPT Institutional Ownership IDYA Institutional Ownership INDV Institutional Ownership BLTE Institutional Ownership This page (NASDAQ:CAPR) was last updated on 6/28/2025 by MarketBeat.com Staff From Our Partners3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Capricor Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Capricor Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
